Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| MINT-PERINDOPRIL | MINT PHARMACEUTICALS INC | Actual shortage | 8MG | Updated Report | 2019-10-21 | 95941 |
| OXYTOCIN INJECTION USP | PFIZER CANADA ULC | Anticipated shortage | 10UNIT | Updated Report | 2019-10-21 | 95607 |
| OXYTOCIN INJECTION USP | PFIZER CANADA ULC | Actual shortage | 10UNIT | Updated Report | 2019-10-21 | 88234 |
| MIDAZOLAM INJECTION | PFIZER CANADA ULC | Actual shortage | 1MG | Updated Report | 2019-10-21 | 82597 |
| VAQTA | MERCK CANADA INC | Resolved | 50UNIT | Updated Report | 2019-10-21 | 56191 |
| MINT-LOSARTAN/HCTZ DS | MINT PHARMACEUTICALS INC | Actual shortage | 25.0MG 100.0MG | Updated Report | 2019-10-21 | 80811 |
| MINT-LOSARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 12.5MG 50MG | Updated Report | 2019-10-21 | 74450 |
| MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 25.0MG 300.0MG | Updated Report | 2019-10-21 | 80797 |
| MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 12.5MG 150.0MG | Updated Report | 2019-10-21 | 80792 |
| TARO-ROSUVASTATIN | SUN PHARMA CANADA INC | Actual shortage | 10MG | New Report | 2019-10-21 | 96908 |
| TARO-ROSUVASTATIN | SUN PHARMA CANADA INC | Actual shortage | 10MG | New Report | 2019-10-21 | 96901 |
| MED-LATANOPROST | GENERIC MEDICAL PARTNERS INC | Actual shortage | 50MCG | Updated Report | 2019-10-21 | 89972 |
| TARO-ROSUVASTATIN | SUN PHARMA CANADA INC | Actual shortage | 40MG | Updated Report | 2019-10-21 | 75286 |
| RAN-VENLAFAXINE XR | RANBAXY PHARMACEUTICALS CANADA INC. | Actual shortage | 150MG | New Report | 2019-10-21 | 96896 |
| RAN-VENLAFAXINE XR | RANBAXY PHARMACEUTICALS CANADA INC. | Actual shortage | 75MG | New Report | 2019-10-21 | 96893 |
| KETODERM CREAM 2% | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Actual shortage | 2% | New Report | 2019-10-21 | 96890 |
| TARO-CLINDAMYCIN | TARO PHARMACEUTICALS INC | Actual shortage | 1% | New Report | 2019-10-21 | 96886 |
| CANDESARTAN | SANIS HEALTH INC | Anticipated shortage | 32MG | New Report | 2019-10-21 | 96884 |
| CANDESARTAN | SANIS HEALTH INC | Anticipated shortage | 8MG | New Report | 2019-10-21 | 96880 |
| TARO-DIPYRIDAMOLE/ ASA | TARO PHARMACEUTICALS INC | Actual shortage | 25MG 200MG | Updated Report | 2019-10-21 | 96362 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| VINORELBINE TARTRATE FOR INJECTION | TEVA CANADA LIMITED | Discontinued | 10MG | New Report | 2019-10-17 | 96695 |
| BLUE COLLYRIUM | SANDOZ CANADA INCORPORATED | Discontinued | New Report | 2019-10-15 | 96619 | |
| BETAJECT | SANDOZ CANADA INCORPORATED | Discontinued | New Report | 2019-10-15 | 96616 | |
| ATRACURIUM BESYLATE INJECTION | SANDOZ CANADA INCORPORATED | Discontinued | New Report | 2019-10-15 | 96613 | |
| ALFENTANIL INJECTION USP | SANDOZ CANADA INCORPORATED | Discontinued | New Report | 2019-10-15 | 96610 |
